Recurrent Uterine Corpus Carcinosarcoma: Clinical Trials

2 trials for Recurrent Uterine Corpus Carcinosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1
Phase 11Active not recruiting 1

Follow Recurrent Uterine Corpus Carcinosarcoma: new trials by email Literature Review of Recurrent Uterine Corpus Carcinosarcoma trials Research Report on Recurrent Uterine Corpus Carcinosarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
Biopsy, Carboplatin, Paclitaxel - Lynch Syndrome, Recurrent Endometrial Carcinoma
Early Phase 1TerminatedFloor Backes, MD22021-07-012025-02-13
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
Biopsy, Computed Tomography, Fluorine F 18 Tetrafluoroborate - Metastatic Endometrial Carcinoma, Recurrent Endometrial Adenocarcinoma
Phase 1Active not recruitingMayo Clinic342017-09-152026-07-21

Narrower conditions

Endometrial Neoplasms (2)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (1)  ·  Turcot syndrome (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Diseases (2)  ·  Uterine Neoplasms (2)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  DNA Repair-Deficiency Disorders (1)

Interventions

Biopsy (2)  ·  Carboplatin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Paclitaxel (1)  ·  Radionuclide Generators (1)  ·  Sodium Pertechnetate Tc 99m (1)  ·  Specimen Handling (1)  ·  Taxes (1)  ·  ruxolitinib (1)  ·  sodium-iodide symporter (1)  ·  tislelizumab (1)

Sponsors

Floor Backes, MD (1)  ·  Mayo Clinic (1)

Countries

United States (2)

Top investigators

Floor Backes, MD (1)  ·  Jamie N. Bakkum-Gamez, M.D. (1)

NIH funding

R01CA207240 (1)